Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding.

Miklos Pless , Koenraad Norga , Martin Carroll , Markus H. Heim
Blood 89 ( 9) 3175 -3185

25
1997
Swiss trials in thoracic oncology

O. Gautschi , Miklos Pless
memo - Magazine of European Medical Oncology 3 ( 1) 37 -40

2010
Current and future developments of immunotherapy in lung cancer

Laetitia A. Mauti , Tobias Finazzi , Martin Früh , Miklos Pless
Memo – Magazine of European Medical Oncology 11 ( 2) 122 -131

2018
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.

Catharina Balmelli , Nikola Railic , Marco Siano , Kristin Feuerlein
Journal of Cancer 9 ( 2) 250 -255

16
2018
14
1996
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability.

Diem Vuong , Stephanie Tanadini-Lang , Ze Wu , Robert Marks
Frontiers in Oncology 10 578895

2020
Significant Progress in Palliative Treatment of Non-small Cell Lung Cancer in the Past Decade

Frank Waechter , Jakob Passweg , Michael Tamm , Martin Brutsche
Chest 127 ( 3) 738 -747

20
2005
[Testicular Cancer: Diagnostics, Therapy and Follow Up].

Martin Kälin , Laetitia Mauti , Miklos Pless
Praxis Journal of Philosophy 105 ( 11) 643 -648

2016
Early Treatment Response in Non-Small Cell Lung Cancer Patients Using Diffusion-Weighted Imaging and Functional Diffusion Maps – A Feasibility Study

Carolin Reischauer , Johannes Malte Froehlich , Miklos Pless , Christoph Andreas Binkert
PLoS ONE 9 ( 10) e108052

12
2014
Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approach.

Roger Stupp , Daniel Betticher , Hans-Beat Ris , Solange Peters
Journal of Clinical Oncology 29 ( 5)

6
2011
95
2011
A phase I study with oral SU5416 in patients with advanced solid tumors: a drug inducing its clearance.

Marc Salzberg , Miklos Pless , Christoph Rochlitz , Klara Ambrus
Investigational New Drugs 24 ( 4) 299 -304

10
2006
Homonymous Hemianopsia in a Patient With Hodgkin's Lymphoma in Remission After BEACOPP Chemotherapy

Cornelia Bruessow , Urs Karrer , Jacques Gubler , Miklos Pless
Journal of Clinical Oncology 30 ( 12)

2
2012
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

Alessandra Curioni-Fontecedro , , Jean Yannis Perentes , Hans Gelpke
British Journal of Cancer 120 ( 10) 968 -974

3
2019
PET-Negative Gastrointestinal Stromal Tumors.

Anja Williams , Andreas Gutzeit , Michael Germer , Miklos Pless
Case Reports in Oncology 6 ( 3) 508 -513

3
2013
Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib.

Sven Bontognali , Miklos Pless , Martin H. Brutsche , Claude Fischer
Onkologie 36 ( 4) 161 -166

4
2013
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01).

Martin Früh , Daniel C Betticher , Roger Stupp , Alexandros Xyrafas
Journal of Thoracic Oncology 14 ( 1) 115 -123

5
2019
A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer

Rodryg Ramlau , Elisabeth Quoix , Janusz Rolski , Miklos Pless
Journal of Thoracic Oncology 3 ( 7) 735 -744

221
2008
P-549 Progress in palliative chemotherapy for NSCLC? Effects of modern chemotherapy regimens

Miklos Pless , Frank Waechter , Jakob R. Passweg , Richard Herrmann
Lung Cancer 41

2003